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Abstract
Introduction. The aim of this study was to determine whether HPV DNA test after cold 
knife conization is a predictive factor for CIN persistence or recurrence. The study also 
investigated whether HPV DNA test results should influence post cold knife excision 
surveillance.
Materials and methods. A retrospective observation study was performed on 738 
patients who underwent cold knife conization for CIN or microinvasive cervical cancer at 
the University Clinic of Obstetrics & Gynecology, Medical Faculty, Ss. Cyril and 
Methodius University, Skopje from 1st June 2007 to 1st June 2009. A total of 217 
patients met the inclusion criteria and were with complete data. The follow-up HPV DNA 
testing was performed at 8 months after cold knife conization, after which the patients 
were followed-up every 4 months till 24 months postoperatively.
Results. HPV DNA testing after 8 months after conization showed that 44 patients were 
HPV DNA positive and 199 were HPV DNA negative. Recurrent cytological 
abnormalities were found in 26 of the 44 HPV DNA positive patients, and in 12 of the 
199 HPV DNA negative patients. Analysis showed that a positive HPV DNA result was 
a risk factor for recurrent/persistent cervical intraepithelial neoplasia.
Conclusion. HPV DNA testing 8 months after conization is important for predicting the 
risk of disease: persistence or recurrence. In addition, such testing can assist in 
designing patient management, since HPV DNA negative patients should undergo 
routine surveillance, while HPV DNA positive patients should undergo frequent and 
meticulous surveillance.
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